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a  b  s  t  r  a  c  t
In vitro  estimating  strategies  for  potential  neurotoxicity  are  required  to screen  multiple
substances.  In a previous  study,  we  showed  that exposure  to  low-concentrations  of  some
chemicals,  such  as organotin,  decreased  the  expression  of  GluR2  protein,  which  is  a subunit
of alpha-amino-3-hydroxy-5-methyl-4-isoxazole  propionic  acid  (AMPA)-type  glutamate
receptors,  and  led to neuronal  vulnerability.  This  result  suggested  that  GluR2  decreases  as an
index  of  neuronal  cell  sensitivity  and  vulnerability  to various  toxic  insults.  Accordingly,  we
developed  a  versatile  method  that  is a large  scale  determination  of GluR2  protein  expression
in the  presence  of  environmental  chemicals  by means  of  AlphaLISA  technology.  Various
analytical  conditions  were  optimized,  and  then  GluR2  protein  amount  was  measured  by
the  method  using  AlphaLISA.  The  GluR2  amounts  were  strongly  correlated  with  that  of
measured  by  western  blotting,  which  is  currently  used  to determine  GluR2  expression.
An  ideal  standard  curve  could be  written  with  the  authentic  GluR2  protein  from  0  ng toNitenpyram 100 ng.  Subsequently,  twenty  environmental  chemicals  were  screened  and  nitenpyram  was
identiﬁed  as a  chemical  which  lead  to decrease  in  GluR2  protein  expression.  This  assay  may
provide  a tool  for detecting  neurotoxic  chemicals  according  to  decreases  in GluR2  protein
expression.
© 2014  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under
the  CC BY license  (http://creativecommons.org/licenses/by/4.0/).Abbreviations: AMPA receptor, alpha-amino-3-hydroxy-5-methyl-4-
isoxazole propionic acid receptor; DMEM,  Dulbecco’s modiﬁed Eagle’s
medium; DMSO, dimethyl sulfoxide; EDTA, ethylenediaminetetraacetic
acid; FCS, fetal calf serum; Glu, glutamate; HS, horse serum; MAP2,
microtubule-associated protein 2; NAS, 1-naphthylacetylspermine; PBS,
phosphate-buffered saline; TBT, tributyltin; WST-1, 2-(4-iodophenyl)-3-
(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium.
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(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Mammals have been chronically exposed to envi-
ronmental chemicals at low concentrations, and some
environmental chemicals induce toxicity in individuals and
in ecological systems. Thus, investigations of toxic environ-
mental chemicals are necessary to prevent exposure. The
central nervous system plays key roles in neuropsychiatric
functions, such as behavior, learning, and memory, and
comprises neuronal cells that recover poorly from damage.
Life-long exposures to neurotoxic chemicals reportedly
leads to altered behavior, mental retardation, and other
neuronal disabilities, as well as diseases [1–3]. Moreover,
during developmental stages, the immature blood–brain
This is an open access article under the CC BY license
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were used for experiments at 11 DIV. This protocolC. Sugiyama et al. / Toxic
arrier allows the passage of neurotoxic environmental
hemicals, even at low concentrations [4,5]. Therefore, an
ndex for neurotoxicity and a screening system for the
ndex are required.
We  previously showed that long-term exposure of
at cortical neurons to low concentrations of organotin
ecreases GluR2 protein expression, leading to increased
euronal susceptibility to glutamate stimulation com-
ared with that in control neurons [6]. Subsequently, we
howed that long-term lead exposure induces neuronal
ell death in association with decreased GluR2 expression
7]. The GluR2 protein is a subunit of the alpha-amino-
-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)
eceptor, which is a glutamate receptor that mediates rapid
xcitatory synaptic transmissions in the central nervous
ystem. GluR2 is critical for Ca2+ permeability of AMPA
eceptors. GluR2-containing AMPA receptors are imperme-
ble to Ca2+ [8], whereas GluR2-lacking AMPA receptors
re highly permeable to Ca2+ in a steady state, and the
ajority of functional AMPA receptors contain GluR2 [9].
luR2 plays important roles in neuronal death, such as that
ssociated with ischemia or Alzheimer’s disease [10–12].
n addition, recent studies show that GluR2 is an essential
egulator of the memory phenomena [13]. These studies
uggest that decreases in GluR2 may  be utilized as an index
or conditions under which neuronal cells are sensitive
nd vulnerable to other stimulants. To investigate multiple
eurotoxic chemicals for their effects on GluR2 expres-
ion, we need large-scale determinations of GluR2 protein
xpression in neuronal cells. However, western blotting
or GluR2 expression is unsuitable for high throughput
creening.
AlphaLISA® (developed by PerkinElmer, Inc.) is applied
o high throughput screening methods with high repro-
ucibility [14–16]. This analysis is a bead-based proximity
mmunoassay [17] that exploits oxygen channeling tech-
ology. AlphaLISA assays are performed with anti-analyte
a target protein) antibodies and two AlphaLISA beads,
ncluding streptavidin-coated alpha donor beads and
gG-coated alpha acceptor beads. AlphaLISA is an all-in-
ne-well assay that does not require transfer or wash steps,
nd allows assessments of analytes on a large scale [18].
In this study, we developed a novel in vitro assay to
creen multiple compounds for their effects on GluR2
xpression by means of AlphaLISA technology (Fig. 1). Sub-
equently, twenty potentially neurotoxic chemicals were
creened, and then nitenpyram was identiﬁed as a novel
hemical which lead to decrease in GluR2 protein expres-
ion.
. Materials and methods
.1. Materials
Eagle’s minimal essential salt medium (Eagle’s MEM)
as purchased from Nissui Pharmaceutical (Tokyo, Japan).
etal calf serum (FCS) was purchased from Nichirei Bio-
ciences (Tokyo, Japan). Horse serum (HS) was purchased
rom Gibco (Life Technologies, Carlsbad, CA, USA). Aciﬂuo-
fen, bithionol, bromofenofos, carbofuran, cis-permethirin,
-(+)-glucose, 4,4′-dichlorobenzophenone, dertamethrin,ports 2 (2015) 450–460 451
diclofop, dimethyl sulfoxide (DMSO), fensulfothion, fen-
thion, methiocarb, NaHCO3, nitenpyram, nitrixynil, ortho
phenyl phenol, oxyclozanid, phenylmethylsulfonyl ﬂu-
oride (PMSF), procloraz, rafoxianid, Sodium dodecyl
sulfate (SDS), tribromsalan and 2-(4-iodophenyl)-3-(4-
nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium (WST-
1) were purchased from Wako (Tokyo, Japan). Allethrin,
arabinosylcytosine, anti--actin antibody (AC-15) and
1-naphthylacetylspermine (NAS) were purchased from
Sigma–Aldrich (St. Louis, MO,  USA). Pentobarbital was
purchased from Kyoritsu (Tokyo, Japan). Captafol and
dichlorvos were purchased from Kanto Chemical Co.,
Inc. (Tokyo, Japan). Tris–HCl, nonidet P-40, ethylene-
diaminetetraacetic acid (EDTA), mercaptoethanol, and
protease inhibitor cocktail were purchased from Nacalai
Tesque (Kyoto, Japan). pGEX-6P and PreScission protease
were purchased from GE healthcare (Piscataway, NJ). BL-
21-CodonPlus (DE3) RIPL was  purchased from Agilent
Technologies (Santa Clara, CA). Mouse anti-GluR2 mono-
clonal antibody (MAB397) was  purchased from Millipore
(Billerica, MA,  USA). Rabbit anti-GluR2 pAb (BS3658) was
purchased from Bioworld Technology, Inc. (St. Louis, MN,
USA). ChromaLinkTM Biotin (DMF Soluble) was purchased
from solulink (San Diego, CA, USA). Zeba Desalt Spin
Columns (0.5 mL)  and PierceTM BCA Protein Assay Kits were
purchased from Thermo Fisher Scientiﬁc K.K. (Rockford,
IL, USA). Bromoxynil was  purchased from Dr. Ehrenstorfer
GmbH (Augsburg, Germany).
AlphaLISA streptavidin donor micro-beads (676002S),
anti-rabbit IgG (Fc speciﬁc) AlphaLISA acceptor beads
(AL104C), AlphaLISA immunoassay buffer (AL000C), and
1/2 AreaPlate-96 plates were purchased from PerkinElmer,
Inc. (Waltham, MA02451, USA).
2.2. Cell culture
The present study was  approved by the animal ethics
committee of Hiroshima University. The following proce-
dures were performed under sterile conditions. Primary
cultures were obtained from the cerebral cortex of fetal
rats (at 18 days of gestation) as described previously
[19]. Fetuses were taken from pregnant Slc; Wistar/ST
rats under pentobarbital anesthesia. Subsequently, parts
of the cerebral cortex were dissected using a razor
blade, and cells were dissociated by gentle pipetting
and plated on culture plates (4 × 106 cells/cm2). Cul-
tures were incubated in Eagle’s MEM  supplemented with
10% fetal calf serum, l-glutamine (2 mM),  d-(+)-glucose
(11 mM),  NaHCO3 (24 mM),  and HEPES (10 mM).  Cul-
tures were maintained at 37 ◦C in a humidiﬁed 5% CO2
atmosphere. Cultures were incubated in MEM  contain-
ing 10% FCS (1–7 days) or 10% HS (8–11 days) and the
medium was exchanged every 2–3 days. Arabinosylcy-
tosine (10 M)  was  added to inhibit the proliferation
of non-neuronal cells at 6 days in vitro (DIV). Cultureshas been shown to produce cultures containing approx-
imately 90% neurons, as indicated by immunostaining
for the neuron marker, microtubule-associated protein 2
(MAP2).
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Fig. 1. AlphaLISA assay of GluR2 protein expression. (A) Principles of the AlphaLISA assay; biotinylated anti-GluR2 mouse monoclonal antibody binds
l antibo
excitatio
lting in astreptavidin-coated alpha donor beads and anti-GluR2 rabbit polyclona
recognize GluR2, allowing the beads to come into close proximity. The 
molecules that trigger an energy transfer cascade in acceptor beads, resu
2.3. Sample preparation
Cultures were used at 11 DIV. After chemical treatment,
cells were washed with PBS and lysed in TNE buffer con-
taining 50 mM Tris–HCl, 1% nonidet P-40, 20 mM EDTA,
Protease Inhibitor Cocktail (1:200), and 1 mM PMSF. Mix-
tures were mixed by rotation at 4 ◦C and were centrifuged
at 15,000 rpm; supernatants were used as cell lysates for
AlphaLISA assays and western blotting.
2.4. Biotinylation and desalting of anti-GluR2 antibodies
Two kinds of anti-GluR2 antibodies with differing
recognition sites on the GluR2 protein were selected for
AlphaLISA, including mouse anti-GluR2 monoclonal anti-
body, which recognizes 175–430 amino acids of GluR2
protein, and rabbit anti-GluR2 polyclonal antibody, which
recognizes 850–880 amino acids of GluR2 protein. Biotiny-
lation of mouse anti-GluR2 monoclonal antibody was
performed using ChromaLinkTM Biotin (DMF Soluble;
Solulink). Brieﬂy, 100 l of 1 mg/ml  antibody, 7.6 l of
2 mg/ml  NHS-ChromaLink-biotin reagent, and 92.4 l of
PBS were incubated for 2 h at 23 ◦C. The biotinylated anti-
body was puriﬁed using a Zeba Desalt Spin Column of
0.5 mL  (Thermo Fisher Scientiﬁc K.K) according to the man-
ufacturer’s protocol. After biotinylation, absorbances at
280 nm (protein), 354 nm (biotin), and 450 nm (turbidity)
were determined using a MultiskanTM GO (Thermo Fisher
Scientiﬁc K.K). The number of biotins per antibody was
calculated using a ChromaLink Biotin E1% MSR  Calculatordy binds anti-rabbit IgG-coated alpha acceptor beads. Both antibodies
n of the donor beads at 680 nm provokes the release of singlet oxygen
 sharp emission peak at 615 nm. (B) AlphaLISA assay protocol.
according to absorbance values. Desalting of rabbit anti-
GluR2 polyclonal antibody was also performed using a Zeba
Desalt Spin Column of 0.5 mL.
2.5. AlphaLISA assay
The AlphaLISA assay was performed in a ﬁnal volume
of 50 l containing cell lysates, biotinylated mouse anti-
GluR2 monoclonal antibody, rabbit anti-GluR2 polyclonal
antibody, streptavidin-coated donor beads, and anti-rabbit
IgG AlphaLISA acceptor beads. Cell lysates were prepared
in TNE buffer and the other reagents were diluted with
AlphaLISA immunoassay buffer. Dilute solutions were used
as negative controls.
Cell lysate (5 l) and two  kinds of anti-GluR2 antibod-
ies (in 10 l) were added to 1/2 AreaPlate-96 culture plates
(PerkinElmer, Inc.) and were incubated at 23 ◦C (1st incu-
bation). Subsequently, 20 ng/mL streptavidin-coated donor
beads (12.5 l) were added and incubated (2nd incuba-
tion), and then 20 ng/ml of acceptor beads (12.5 l) were
added and incubated (3rd incubation) in the dark. Mea-
surements were performed using a multimode plate reader
(EnspireTM; PerkinElmer, Inc.).
Each examination was  carried out on clamped condi-
tions as follows:• Determinations of antibody concentrations; 1st incu-
bation time, 2 h; 3rd incubation time, 4 h; protein
concentration, 3000 ng.
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Determinations of protein abundance; 1st incuba-
tion time, 2 h; 3rd incubation time, 4 h; biotinylated
anti-GluR2 monoclonal antibody, 10 nM;  anti-GluR2
polyclonal antibody, 5 nM.
Assessments of incubation times; biotinylated anti-
GluR2 monoclonal antibody, 10 nM;  anti-GluR2 poly-
clonal antibody, 5 nM;  protein concentration, 3000 ng.
.6. Generation of GluR2 constructs
GluR2 constructs were generated using inverted PCR
ith the following oligonucleotides:
PRM1, TCTAGAATGCAAAAGATTATGCATATTTCTGTC;
PRM2, GCGGCCGCCTAAATTTTAACACTCTCGATGCCATAT-
AC;
PRM3, AAGAAAGGAAAACACTCCTGGTTTG;
PRM4, GAGTTCTGTTACAAGTCAAGGGCC;
PRM5, GGATCCGAGAAGAAGTGGCAGGTGACTGCTATC.
GluR21–169, 539–834 fragments were constructed
sing a three-step PCR process. First, GluR2 gene fragments
ere ampliﬁed from rat brain cDNA using the primers
RM1 and PRM2, and ampliﬁed fragments were ligated
nto pBlueScript II. Second, the GluR2539–834 gene was
mpliﬁed from pBlueScript II/GluR2 using the primers
RM3 and PRM4. Third, the GluR21–169, 539–834 gene
as ampliﬁed from pBlueScript II/GluR2539–834 using
he primers PRM5 and PRM2. The GluR21–169, 539–834
ragment was then digested using BamHI and NotI and was
loned into pGEX-6P.
.7. GluR21–169, 539–834 protein expression
Expression of GST-tagged GluR21–169, 539–834 pro-
ein in Escherichia coli strain BL-21-CodonPlus (DE3) RIPL
as induced using 0.1 mM IPTG at 37 ◦C for 1 h. Bacterial
ellets were stored at −80 ◦C. Subsequently, bacterial pel-
ets from 8-L cultures were thawed in extraction buffer
ontaining 20 mM Tris–HCl (pH 8.0), 50 mM NaCl, 5 mM
DTA, 10 mM DTT, 0.1% Triton-X100, 1 mM PMSF, 2 M
eupeptin, and 2 M pepstatin A, and were sonicated at
ild intensity. After centrifugation for 30 min  at 24,000 × g,
xtracts were rotated with 1 mL  of glutathione sepharose
t 4 ◦C for 2 h, and then sepharose was washed using diges-
ion buffer containing 50 mM Tris–HCl (pH 7.0), 150 mM
aCl, 1 mM EDTA, 1 mM DTT, 0.1% Triton-X 100, and
% glycerol. For enzyme digestion, sepharose was incu-
ated overnight with 20 L of PreScission protease at 4 ◦C.
igested GluR21–169, 539–834 protein was dialyzed
gainst buffer containing 20 mM Tris–HCl (pH 7.0), 150 mM
aCl, 1 mM EDTA, and 1 mM DTT, and was used as a puriﬁed
luR2 standard.
.8. Western blotting
Western blotting experiments were performed as
escribed previously [20]. Brieﬂy, supernatants were added
o the sample buffer containing 100 mM Tris–HCl, 4% SDS,
0% glycerol, 0.004% bromophenol blue, and 5% mercap-
oethanol, and were then denatured at 95 ◦C for 3 min.ports 2 (2015) 450–460 453
Proteins were separated using SDS-polyacrylamide gel
electrophoresis and were transferred to polyvinylidene
diﬂuoride membranes. Membranes were blocked with a
blocking buffer containing 5% skim milk for 1 h, and were
then incubated with anti-GluR2 (1:2000) and anti--actin
(1:8000) antibodies overnight at 4 ◦C. After incubation with
secondary antibody for 1 h, proteins were detected using an
enhanced chemiluminescence detection system [Chemi-
Lumi One L, Nacalai Tesque (Kyoto, Japan)]. Quantitative
analyses were performed using digital imaging software
[Image J, NIH (Bethesda, MD,  USA)], and GluR2 protein lev-
els were normalized to those of -actin. Western blotting
was performed to conﬁrm associations of anti-GluR2 anti-
body with either donor beads or acceptor beads and the
subsequent formation of the complex for AlphaLISA assays.
2.9. Cell viability assay
Trypan blue dye exclusion assays and WST-1 assay
were performed to assess neurotoxicity. Trypan blue dye
exclusion assays were performed as described in pre-
vious reports [19]. After exposure to nitenpyram, cell
cultures were immediately stained with 1.5% trypan blue
for 10 min. Subsequently, the cells were ﬁxed with 10%
formalin for 2 min  and rinsed with physiological saline.
Unstained cells were considered viable and stained cells
were considered dead. Cell viability of cultures was calcu-
lated as the percentage ratio of the number of unstained
cells to total cells counted. Over 200 cells per well were
randomly counted. In WST-1 assay, after exposure to
nitenpyram, a mixed solution of WST-1, 1-methoxy-5-
methylphenazinium methylsulfate, and DMEM was  added
to each well, and the plate was incubated for 1 h. Finally,
the supernatants were transferred to the wells of a 96-
well plate, and the absorption was measured at 415 nm,
the maximum wavelength of the formazan dye, with a
Microplate reader, MultiscanTM GO (Thermo Scientiﬁc).
2.10. Statistics
All the experiments were replicated and representative
data were shown. Data are expressed as means ± standard
errors of the mean (SEM). Statistical analyses were per-
formed using ANOVA followed by Tukey’s test, and
differences were considered signiﬁcant when p < 0.05.
3. Results
3.1. Complex formation for AlphaLISA assays
Because AlphaLISA is based on the sandwich conﬁgura-
tion, associations of each anti-GluR2 antibody with either
donor beads or acceptor beads, and formation of corre-
sponding complexes, were conﬁrmed by means of western
blotting with AlphaLISA reaction mixtures (Fig. 2). As in
the AlphaLISA protocol in Fig. 1B, cell lysates contain-
ing GluR2 protein, anti-GluR2 antibodies, and beads for
AlphaLISA were added and incubated for 2 h. Subsequently,
two types of mixtures were prepared by incubation with-
out donor or acceptor beads and were then centrifugation
at 15,000 rpm for 15 min  to separate bead and buffer
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Fig. 2. GluR2 complex formation for AlphaLISA assays. (A) Cell lysates, anti-GluR2 antibodies, and AlphaLISA beads were incubated in microtubes without
anti-rabbit IgG-coated alpha acceptor beads or without streptavidin-coated alpha donor beads. After incubation, bead fractions were separated by centrifu-
 with ex
tern blo
ffer wasgation at 15,000 rpm for 15 min. (B) Western blotting of fraction [1] buffer
and  GluR2. TNE buffer with cell lysis buffer was  used as a control. (B) Wes
[2], beads bound with antibodies and GluR2. TNE buffer with cell lysis bu
fractions. As a control, TNE buffer was added instead
of cell lysates [GluR2(−)]. GluR2 protein and anti-GluR2
antibodies in each mixture were detected by means of
western blotting. In samples without donor beads and in
samples without acceptor beads, GluR2 and anti-GluR2
antibodies were concentrated in the precipitated beads
fraction [GluR2(+)] compared with the fraction from con-
trol samples [GluR2(−); Fig. 2]. These data demonstrate
the formation of essential complexes between the tested
anti-GluR2 antibodies and beads, and validate their use in
AlphaLISA assays of GluR2 in cell lysates.
3.2. Optimization of assay conditions
All antibodies had bead-binding capacity and the peak
AlphaLISA signals were observed before saturation (hook
point). Optimal concentrations of each antibody were
identiﬁed according to bell-shaped curves of biotinylated
mouse anti-GluR2 monoclonal antibody signals (Fig. 3A).
The peak signal was observed at 12.8 nM indicating
the hook point. In subsequent optimization experiments,
biotinylated anti-GluR2 monoclonal antibody was  used
at the sub-hooking concentration of 10 nM.  A saturated
curve was obtained for rabbit anti-GluR2 polyclonal anti-
body (Fig. 3B), which required coupling to anti-rabbit IgG
antibodies on acceptor bead surfaces. Under these condi-
tions, acceptor beads became saturated with anti-GluR2
antibody, which was used at 5 nM to avoid saturation
in further experiments. Hook points were also found intra antibodies and extra GluR2; fraction [2] beads bound with antibodies
tting of fraction [1], buffer with extra antibodies and extra GluR2 fraction
 used as a control.
AlphaLISA experiments with cell lysates from rat primary
cerebral cortical neurons, allowing determination of opti-
mum  protein amount in cell lysates (Fig. 3C). An AlphaLISA
saturation curve was obtained using lysates from unex-
posed rat primary cerebral cortical neurons and was linear
up to about 5000 ng (R2 = 0.97; Fig. 3D). Thus, cell lysates
with a protein content of 3000 ng were used in further
experiments.
Reactions of both the 1st and the 3rd incubations of anti-
bodies were enhanced with the duration of incubation. A
time-dependent increase was  also observed at both 1st and
3rd incubation times, and counts did not saturate (Fig. 3E).
Therefore, for further experiments the 1st and the 3rd incu-
bation times were set at 6 and 15 h, respectively.
3.3. Correlation between western blotting analyses and
AlphaLISA assays
After optimizing assay conditions, in order to validate
the present AlphaLISA assay, experiments were performed
with a puriﬁed GluR2 standard. GluR2 is a predicted six-
transmembrane protein (Fig. 4A) and we  generated GluR2
constructs using inverted PCR (Fig. 4B). In these experi-
ments AlphaLISA signals were linear up to 100 ng (R2 = 0.98;
Fig. 4C) and were speciﬁc to the GluR2 protein. In addi-
tion, two  kinds of the GluR2 determinations, AlphaLISA and
western blotting, were conducted to the identical samples
which contains 0–100 ng GluR2 standard, and the result
showed strong correlation between the methods (R2 = 0.99,
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nti-GluR2 rabbit polyclonal antibody. Data are expressed as the mean ± 
ig. 4D). The correlation indicated that the present AlphaL-
SA assay can be used as an alternative for western blotting.
oreover, we investigated the interference of the other
roteins except GluR2 protein by means of the lysate of
6 cells. We  conducted to the identical samples which
ontain the GluR2 standard and the lysates of C6 cells.
he result showed strong correlation between the meth-
ds (R2 = 0.97, Fig. 4E) in the presence of the protein from
6 cells and there is slightly difference compared with
he samples which only contains GluR2 standard and TNE
uffer (Fig. 4C).
.4. Identiﬁcation of nitenpyram as a novel suppressor of
luR2 expression
Twenty environmental chemicals were screened for
he effect on GluR2 expression by means of the present
lphaLISA method. We  previously showed that long-term
xposure of rat cortical neurons to environmental chem-
cals, organotin and lead, led to decreased GluR2 protein
xpression and greater susceptibility of neurons to gluta-
ate stimulation [6,7]. However, We  think GluR2 decrease
ay  be caused by other environmental chemicals besidesntiﬁed using bicinchoninic acid (BCA) protein assays; (D) enlarged view
d anti-GluR2 antibodies; 3rd incubation, binding of acceptor beads and
 error of the mean (n = 3).
metals, and screened the other type of environmental
chemicals, such as agricultural chemicals. We  selected
twenty environmental chemicals which have various prin-
ciple uses, such as pesticide, antiparasitic, herbicide and
bactericide as test compounds for screening. Neuronal
cells were exposed to DMSO (control) or test compounds
for 9 days at the concentration of 1 M and 10 M
(Table 1). As the results, the neonicotinoid insecticide
nitenpyram decreased the most in GluR2 expression. In
subsequent experiments, cortical neurons were exposed
to 0.1–100 M nitenpyram for 9 days and GluR2 expres-
sion was  measured. As we previously reported that showed
that long term exposure to 20 nM tributyltin (TBT) leads to
decreased GluR2 protein expression in rat cortical neurons
[6]. TBT-treated cortical neurons were used as a positive
control, and GluR2 expression was reduced by nitenpyram
in a dose-dependent manner and the reduction was  signif-
icant at concentrations above 10 M (Fig. 5A). AlphaLISA
and western blotting were conducted to the identical sam-
ples which were obtained from neuronal cells which were
exposed to 0–100 M nitenpyram, and the result showed
strong correlation between the methods (R2 = 0.86, Fig. 5B),
which indicated that AlphaLISA assay is useful to assess the
456 C. Sugiyama et al. / Toxicology Reports 2 (2015) 450–460
Fig. 4. Schematic representation of GluR2 protein and AlphaLISA assay. (A) GluR2 is a predicted six-transmembrane protein; (B) Schematics of the
GluR21–169,  539–834 construct; numbers above the amino acid residues refer to residues of the full-length receptor; (C) measurement of puriﬁed
GluR2  standard using AlphaLISA. Data are expressed as the mean ± the standard error of the mean (n = 3). (D) Correlation between western blotting anal-
yses  and AlphaLISA assays. Quantitative western blotting analyses of GluR2 protein expression were performed using image J software. (E) Interference
of  the other proteins except GluR2 protein by means of the lysate of C6 cells. AlphaLISA was  conducted using identical samples which contain the GluR2
standard and the lysates of C6 cells.
Table 1
Test compounds for the screening of GluR2 decrease.
Principal use Chemical Mechanism of action AlphaLISA (% of control)
1 M 10 M
Pesticide Dichlorvos Acetylcholinesterase inhibitor 107 89
Fenshlfothion Acetylcholinesterase inhibitor 118 111
Fenthion Acetylcholinesterase inhibitor 90 87
Carbofuran Acetylcholinesterase inhibitor 80 90
4,4′-Dichlorobenzophenone Sodium channel modulator 76 107
Allethrin Sodium channel agonist 97 84
Dertamethrin Sodium channel agonist 100 94
cis-Permethirin Sodium channel agonist 99 84
Nitenpyram Nicotinic acetylcholine receptor agonist 81 66
Antiparasitic Rafoxianide ATP syntesis inhibitor 126 88
Bithionol ATP syntesis inhibitor 98 71
Oxyclozanide Uncoupler of oxidative phosphorylation 103 104
Bromofenofos Uncoupler of oxidative phosphorylation 107 82
Nitrixynil Uncoupler of oxidative phosphorylation 101 99
Tribromsalan Uncoupler of oxidative phosphorylation 83 106
Herbicide Diclofop Acetyl-CoA carboxylase inhibitor 84 105
Aciﬂuorfen Protoporphyrinogen oxidase inhibitor 82 79
Bromoxynil Inhibition of photosynthesis 96 96
Bactericide Procloraz Inhibition of sterol 14-demethylation 145 112
Ortho phenyl phenol 119 93
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f  the mean (n = 4) *p < 0.05, **p  < 0.01 vs. DMSO. (B) Correlation between
nalyses of GluR2 protein expression were performed using image J softw
eurotoxicity of large numbers of hazardous chemicals as
n alternative for western blotting.
.5. Vulnerability of nitenpyram-treated cells to
lutamate stimulation
To determine whether nitenpyram causes cell vulnera-
ility, we assessed glutamine-induced neuronal death in
he presence or absence of nitenpyram. Neurons were
xposed to DMSO (control) or 100 M nitenpyram for 9
ays, followed by 0, 50, or 100 M glutamate for 24 h.
t 50 M concentration, cell viability following glutamate
timulation differed signiﬁcantly between control neurons
nd nitenpyram-treated neurons (Fig. 6A). Moreover, this
ncreased susceptibility of nitenpyram-treated neurons
as abolished by an antagonist of GluR2-lacking AMPA
eceptor, 1-naphthylacetylspermine (NAS) (Fig. 6B and C).
. Discussion
Some environmental chemicals are believed to have
eurotoxicity at low concentrations [3]. However, small
umbers of chemicals have been assessed for neurotoxicity
s well-developed methods and markers of neurotoxicity
re not available. Analyses of behavioral and neuropatho-
ogical changes in vivo provide powerful tools for assessing
eurotoxicity [21]. Since such analyses are time consum-
ng and expensive, they are unsuitable for neurotoxicity
creening of multiple chemicals, necessitating a convenient
igh throughput in vitro method [22,23]. Thus, in this study,
e conditioned AlphaLISA assay for the measurement of
luR2 which is known as a key subunit of AMPA recep-
or and dictate Ca2+ permeability. The assay was utilized tolized to those of -actin. Data are expressed as the mean + standard error
n blotting analyses and AlphaLISA assays. Quantitative western blotting
assess decreases in GluR2 expression following long-term
exposure to low concentrations of multiple environmental
chemicals.
AlphaLISA assays are performed with anti-analyte
(a target protein) antibodies and two  AlphaLISA beads,
including streptavidin-coated alpha donor beads and IgG-
coated alpha acceptor beads. In this method, biotinylated
anti-analyte antibodies are conjugated to donor beads
and non-biotinylated anti-analyte antibodies are conju-
gated to acceptor beads. Accordingly, the acceptor bead
is not directly coupled to the analyte-speciﬁc antibody,
but is coupled to another antibody that recognizes the
non-biotinylated anti-analyte antibody. Upon excitation,
a photosensitizer inside the donor bead converts ambient
oxygen to an excited singlet state. In the presence of ana-
lytes, antibodies and beads conjugate analytes, and singlet
oxygen molecules are provoked by donor beads that are
proximal (about 200 nm)  to acceptor beads, triggering a
cascade of chemical events in nearby acceptor beads and
chemiluminescent emissions at 615 nm.
Under optimal conditions, GluR2 protein amount in
AlphaLISA assays and western blotting analyses were
highly correlated (R2 = 0.99, Fig. 4D). The regression line is
corresponding to the unity because the slope is about 1.
Western blotting is used as a standard method for con-
ﬁrming the expression of speciﬁc proteins. However, it
requires electrophoresis and transfer steps, followed by
quantitation of band densities using software, and lacks
quantitative accuracy. In contrast, AlphaLISA is an all-in-
one-well assay that does not require transfer or wash steps
and the signals were quantitative with a puriﬁed GluR2
standard (R2 = 0.98, Fig. 4C), conﬁrming speciﬁcity for the
GluR2 protein. Moreover, the strong correlation between
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 and ce
plied to
or of the(50  M)  was  applied to neurons 30 min  after treatment with 300 M NAS
mean  + standard error of the mean (n = 3). (C) Glutamate (50 M) was  ap
measured by WST-1 assay. Data are expressed as the mean + standard err
AlphaLISA assays and western blotting analyses validates
the present AlphaLISA method as a rapid alternative to
western blotting for measurements of GluR2 expression.
Besides we conﬁrmed that AlphaLISA was not interfered
other cell lysate proteins expect GluR2 using the samples
which contain the GluR2 standard and the lysates of C6
cells (Fig. 4E). This results also suggest that TNE buffer is
enough as a blank, not cell lysates which do not contain
GluR2 protein.
After screening twenty environmental chemicals using
the present method, nitenpyram, one of the neonicotinoid
insecticides, was identiﬁed as a candidate that decreases
GluR2 expression (Table 1). Nitenpyram treatment signif-
icantly increased neuron susceptibility to glutamate and
a GluR2-lacking AMPA receptor antagonist rescued this
susceptibility (Fig. 6), suggesting that nitenpyram-induced
GluR2 decrease leads to susceptibility of neurons. These
results validated the present AlphaLISA method for assess-
ments of neurotoxicity.
Neonicotinoid insecticides are currently the newest and
largest single insecticide class in the market, representing
more than 20% of insecticides used in 2008 globally [24].
Neonicotinoid insecticides are also used to control ﬂeas
and ticks in household pets, and act as selective agonists
of nicotinic acetylcholine receptors (nAChRs) in insects
[25]. However, some reports suggest that neonicotinoidll viability was  measured by trypan blue assay. Data are expressed as the
 neurons 30 min  after treatment with 300 M NAS and cell viability was
 mean (n = 6).
insecticides affect mammalian nAChRs to a greater extent
than previously believed [26–28] and that further studies
of neonicotinoid insecticides are required.
We  developed a new in vitro evaluating method utilizing
decreased GluR2 protein expression results in detectable
neuronal cell vulnerability [6,7], as well as automated
image analyses of neurogenesis and apoptosis. GluR2 is
a subunit that depresses cell permeability to bivalent
cations in a steady state [29,30] and plays an impor-
tant role in glutamatergic neuron signaling. Previous
studies have demonstrated that GluR2 decreases dam-
age active neurons, and that GluR2 knockout mice have
impaired associative learning and reduced anxiety [31]. In
in vitro studies, neurotoxicity is evoked by kainate-acid
stimulation in GluR2-deﬁcient neurons, possibly reﬂect-
ing other GluR2-associated consequences in addition to
Ca2+ permeability [32]. Moreover, decreases in GluR2 pro-
tein expression have been related to neurodegenerative
diseases [10–12]. Accordingly, about 60–70% of AMPA
receptors have intracellular localization [33], but are deliv-
ered to the plasma membrane surfaces as functional AMPA
receptors. Thus, total decreases in GluR2 reﬂect those on
the plasma membrane surface.
We previously showed that long-term exposure of
rat cortical neurons to environmental chemicals led
to decreased GluR2 protein expression and greater
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usceptibility of neurons to glutamate stimulation [6,7].
hese data suggest that GluR2 decreases may  offer an
ndex of neuronal cell sensitivity and vulnerability to other
timuli. However, further studies are needed to conﬁrm
hat GluR2 decreases are a suitable endpoint of neurotox-
city. To this end, comparisons of the effects of multiple
hemicals on GluR2 protein expression using AlphaLISA,
hich is a high throughput screening method with high
eproducibility, will be valuable. In the present study, we
impliﬁed the AlphaLISA procedures following cell solubi-
ization. However, future studies are required to simplify
he pre-measurement processing, such as sample prepara-
ion, to maximize the practical application of the present
ethod. In addition, in the present method, AlphaLISA
eeds three steps for measurement. However, we can
imply the method to two steps by binding the GluR2 anti-
ody with GluR2 antibodies which are used in the present
ethod to acceptor beads in advance (AlphaLISA direct
ssay). AlphaLISA direct assay is capable of improvement in
oth cost and time consumption. In conclusion, we  devel-
ped a simple high throughput measurement method for
luR2 expression by means of AlphaLISA technology. This
lphaLISA method allows comprehensive investigations
f the effects of multiple potentially neurotoxic chemi-
als, and it may  facilitate investigations of the mechanisms
ehind decreases in GluR2 expression.
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